TWO SIGMA ADVISERS, LP - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,073,488
-62.5%
44,098
-66.5%
0.01%
-64.3%
Q1 2023$5,530,244
-7.2%
131,798
-15.7%
0.01%
-17.6%
Q4 2022$5,961,206
+12.5%
156,298
+15.5%
0.02%
+13.3%
Q3 2022$5,298,000
+142.7%
135,298
+100.2%
0.02%
+150.0%
Q2 2022$2,183,000
+60.9%
67,598
+64.9%
0.01%
+50.0%
Q1 2022$1,357,000
-29.4%
41,000
-9.3%
0.00%
-20.0%
Q4 2021$1,923,000
-10.5%
45,200
-6.8%
0.01%
-16.7%
Q3 2021$2,149,000
-83.4%
48,500
-78.7%
0.01%
-82.4%
Q2 2021$12,941,000
-52.3%
227,799
-37.2%
0.03%
-54.7%
Q1 2021$27,148,000
-25.6%
362,699
-14.0%
0.08%
-22.7%
Q4 2020$36,490,000
+12.3%
421,799
-20.6%
0.10%
+4.3%
Q3 2020$32,479,000
+6.7%
531,399
-27.4%
0.09%
+4.5%
Q2 2020$30,437,000
+135.4%
731,999
+62.6%
0.09%
+81.6%
Q1 2020$12,930,000
+1435.6%
450,199
+7403.3%
0.05%
+2350.0%
Q3 2019$842,000
-57.3%
6,000
-52.4%
0.00%
-60.0%
Q2 2018$1,972,000
-63.8%
12,600
-62.7%
0.01%
-66.7%
Q1 2018$5,444,000
+156.2%
33,800
+162.0%
0.02%
+150.0%
Q4 2017$2,125,000
+852.9%
12,900
+360.7%
0.01%
+500.0%
Q2 2017$223,000
-23.4%
2,800
-31.7%
0.00%0.0%
Q1 2017$291,0004,1000.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders